Send us a Message

*
*
*
*

Guildford, UK

ID Business Solutions Ltd.

2 Occam Court
Surrey Research Park
Guildford, Surrey
GU2 7QB
United Kingdom

Tel: +44 1483 595 000
Fax: +44 1483 595 001

London, UK

ID Business Solutions Ltd.

4th Floor, Pembroke Building
Kensington Village
Avonmore Road
London, W14 8DG
United Kingdom

Tel: +44 207 565 8620
Fax: +44 208 237 8441

Paris, France

ID Business Solutions Ltd.

18 Rue Pasquier,
Paris, 75008
France

Tel: +33 01 78 41 44 46

Alameda, California

ID Business Solutions Inc.

1301 Marina Village Parkway
Suite 320,
Alameda, CA 94501

Tel: +1 510 814 4900
Fax: +1 510 814 4910

Bridgewater, New Jersey

ID Business Solutions Inc.

750 US Highway 202,
Suite 200,
Bridgewater, NJ 08807

Tel: +1 908 429 2900
Fax: +1 908 429 2901

Burlington, Massachusetts

ID Business Solutions Inc.

25 Burlington Mall Road
1st Floor, Suite #107
Burlington, MA 01803

Tel: +1 781 272 3355
Fax: +1 781 272 3377

Tokyo, Japan

ID Business Solutions (Japan)

Shibuya Mark City W22F
1-12-1 Dogenzaka Shibuya-ku Tokyo
150-0043 Japan

Tel: +81 3 4360 5344
info-japan@idbs.com

Mumbai, India

Trident Equipments Pvt Ltd

F409/410 Kailas Industrial Complex
Park Site, Vikhroli(W)
Mumbai, 400079
India

David Morris - DMorris@idbs.com
Tel: +912225181705

Shanghai, China

ID Business Solutions

Room 207, Block A, Innovation Building
NO.333 Cailun Road, Zhangjiang High Tech. Park
Shanghai 201203
China

Tel: +86-21-6468-5535/6469-1770
Fax: +86-21-6468-5366

Melbourne, Australia

Conor Higgins
PO box 9079
Brighton
Melbourne
Vic 3186

Conor Higgins - chiggins@idbs.com
Tel: +61 410 708 052

Close

IDBS Press Release

Principal biopharmaceutical company introduces ActivityBase XE to improve screening efficiency

Guildford, United Kingdom, January 29, 2007 - IDBS today announces that long time ActivityBase user, Organon (Oss, The Netherlands and Newhouse, UK), has introduced the XE module into its Molecular Pharmacology departments in Oss and Newhouse. This follows a comprehensive pilot of XE and extensive collaboration with IDBS.

Organon incorporated the ActivityBase test management system in 2002, to improve efficiency in compound screening. Following the release of XE in September 2005, Organon sought to evaluate IDBS' screening-specific module.

Dr Steven van Helden, Section Head for Screening and Technology at Organon, commented: "We have been very satisfied with our ActivityBase installation but constantly look for ways to improve efficiency within our screening process. As we recently introduced a new laboratory automation platform for in-vitro testing it was clear that there was also a desire to improve on our data processing. The attraction of the XE module was the ability to perform verification, analysis and visualisation within one environment. This greatly improves our workflow for High Throughput Screening, Hit Optimisation and Lead Optimisation." Dr van Helden continued: "The designer element of XE, being linked to the context of the experiments, reduces the time and effort associated with template maintenance.

This means we can spend more time analysing data, and less time developing analysis templates."

Neil Kipling, CEO and founder of IDBS, added: "We have many thousands of ActivityBase users - most of whom are engaged in biological screening. The addition of XE to ActivityBase makes it even more applicable and useful to an organisation's HTS program. Providing context around screening results promotes better understanding, which in turn supports better decision-making."

About IDBS

IDBS is a leading provider of integrated software solutions to the life sciences industry. Maximising the value of research data by enabling organisations to capture, store, share and use data efficiently and effectively, whilst protecting intellectual property across the spectrum of discovery activities.

Headquartered in Guildford, UK, IDBS has U.S. offices in California, New Jersey and Massachusetts. IDBS partners with CTC Laboratory Systems in Japan and a network of distributors to market IDBS products and services in Asia. Founded in 1989, IDBS employs more than 150 people worldwide.

About Organon
Organon - with shared head offices in Roseland, NJ, USA and Oss, The Netherlands - creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of independent growth and business partnerships, Organon strives to remain or become one of the leading biopharmaceutical companies in each of its core therapeutic fields: fertility, gynecology, anesthesia and neuroscience. Research areas also include immunology and oncology.
Organon products are sold in over 100 countries, of which more than 60 have an Organon subsidiary. Organon is the human health care business unit of Akzo Nobel.

For media enquiries, please contact:

Danielle Guinebertiere, IDBS Communications Director
Tel: +1-617-547-2500 ext 230
Email: dguinebertiere@idbs.com